Oppenheimer Asset Management Inc. Makes New $21.08 Million Investment in HealthEquity, Inc. $HQY

Oppenheimer Asset Management Inc. purchased a new position in HealthEquity, Inc. (NASDAQ:HQY) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 233,378 shares of the company’s stock, valued at approximately $21,079,000. Oppenheimer Asset Management Inc. owned approximately 0.28% of HealthEquity as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the business. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity in the fourth quarter worth about $27,000. Caitong International Asset Management Co. Ltd grew its position in HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after buying an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in HealthEquity during the 4th quarter valued at about $28,000. Leonteq Securities AG increased its stake in HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after buying an additional 235 shares during the period. Finally, Axiom Investment Management LLC bought a new stake in shares of HealthEquity during the 1st quarter worth about $33,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Down 0.8%

Shares of HealthEquity stock opened at $104.73 on Friday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $107.62. The firm has a market capitalization of $8.76 billion, a PE ratio of 39.22, a price-to-earnings-growth ratio of 1.78 and a beta of 0.21. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock’s fifty day moving average is $95.15 and its 200-day moving average is $86.51.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the firm’s stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the transaction, the executive vice president owned 52,244 shares of the company’s stock, valued at approximately $4,963,180. The trade was a 4.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research note on Monday, June 1st. Barrington Research reissued an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd. Citizens Jmp boosted their target price on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Finally, Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and an average price target of $110.93.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.